The resurgence of covid-19 cases, with the rapid spread of the Delta variant in several countries, Pfizer witnessed growth in quarterly sales. The company said it is in the process of developing a booster dose for the Delta variant.
ADSS Review
Thursday, 29 Jul, 2021 / 10:57
